KIRA OLIVER: Open Payments
NPI 1578294120 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 71 payments from 17 companies in 2025. Trend: 2023 $359 · 2024 $1,637 · 2025 $1,713
Food & beverage: $1,570Education: $142
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $326 |
| Janssen Biotech, Inc. | 11 | $294 |
| ABBVIE INC. | 13 | $259 |
| Galderma Laboratories, L.P. | 7 | $217 |
| GENZYME CORPORATION | 4 | $129 |
| Incyte Corporation | 7 | $122 |
| LNHC, Inc | 3 | $60 |
| Organon LLC | 3 | $47 |
| LEO Pharma Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $44 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, OPZELURA, ZELSUVMI, RINVOQ, AKLIEF.
Industry payments across NY — which companies pay providers there.
